Hyperbaric Oxygen Preconditioning Can Reduce Postabdominoplasty Complications: A Retrospective Cohort Study
Hyperbaric oxygen therapy (HBOT) can improve wound healing and has been found to have positive preconditioning effects in animal models. Among esthetic surgical procedures, abdominoplasty poses the highest rate of postoperative complications. The aim of this study was to evaluate the effect of preoperative HBOT as a preconditioning treatment for expected postsurgical complications.
Methods: We conducted a retrospective cohort study among patients who underwent abdominoplasty at our institute and private practice between January 2012 and November 2017. Patients who received preoperative HBOT were compared with patients who did not receive HBOT. Surgical complication data and demographic, preoperative and postoperative data from patient records were collected.
Results: The study included 356 patients. Of them, 83 underwent HBOT preoperatively. Using preoperative HBOT, postoperative complications were significantly reduced from 32.6% (89 patients) to 8.4% (7 patients), P <0.001. Moreover, 17 (6.2%) patients in the comparison group and none in the HBOT group experienced necrosis (P = 0.016). In the multivariate analysis, preoperative HBOT was an independent protective factor against postoperative complications (odds ratio, 0.188; 95% CI, 0.082–0.432; P < 0.001). After propensity score matching, the study results remained the same.
Conclusions: Preoperative HBOT can reduce postoperative complication rate in abdominoplasty patients. Further prospective studies are necessary to validate the findings and characterize patients who benefit the most from this treatment.
(Plast Reconstr Surg Glob Open 2019;7:e2417; doi: 10.1097/GOX.0000000000002417; Published online 31 October 2019.)








Dr. Wiser is a New York Licensed and Israeli Board Certified Plastic Surgeon. He currently serves as the Chief of Plastic and Reconstructive Surgery at Mount Sinai Elmhurst Hospital. His medical journey includes two prestigious fellowships:
-
A Reconstructive Microsurgery Fellowship at Lenox Hill Hospital, specializing in aesthetic and reconstructive breast surgery.
-
A Lymphedema Surgery Fellowship at Memorial Sloan Kettering Cancer Center.
He also holds a PhD in Epidemiology and Public Health from the Sackler School of Medicine in Israel. This advanced academic background allows him to critically evaluate emerging medical technologies and treatments, including HBOT, through the lens of science and evidence-based medicine.
Scientific studies have shown that HBOT increases oxygen concentration in plasma, stimulates the release of growth factors, reduces inflammation, and enhances cellular repair. The treatment is FDA-approved for specific medical conditions and is widely used in sports medicine for off-label benefits related to recovery and performance.